Erector Spinae Plane Block Versus Subcostal Anterior Quadratus Lumborum Block in Laparoscopic Cholecystectomy
Launched by ZAGAZIG UNIVERSITY · Dec 14, 2021
Trial Information
Current as of September 10, 2025
Completed
Keywords
ClinConnect Summary
Site of the Study: Zagazig university surgical hospitals.
Type of the Study: Prospective randomized double-blinded clinical trial.
Sample Size:
The sample size is calculated to be 27 for each group, assuming that the mean ± standard deviation of 24 hrs postoperative total opioid consumption among group of patients undergoing ESBP technique versus control group is 130 ± 88 and 201 ± 78, respectively. Assuming that US-guided SAQLB will be similar to ESBP technique in 24 hrs postoperative total opioid consumption. with confidence level of 95% and power of test 80%, with 10% drop out.
Withd...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age 18 - 60 years, of both sexes.
- • 2. ASA class II - III.
- • 3. Scheduled to undergo laparoscopic cholecystectomy under general anesthesia.
- • 4. Body mass index (BMI) ≥ 30 kg/m².
- Exclusion Criteria:
- • 1. Age \< 18 or \> 60 years. 2. ASA IV patients. 4. Intraoperative conversion to open surgery. 5. Contraindications of regional anesthesia, e.g., allergy to local anesthetics, coagulopathy or infection at the site of injection.
- • 6. Uncooperative patients or psychiatric disorders. 7. Spinal deformity or previous spine surgery. 8. Chronic use of analgesics or drug dependence. chronic pain characterized by opioid use for \> 30 consecutive days within the 3 preoperative months at a dose equivalent to at least 15 mg of morphine.
About Zagazig University
Zagazig University, a prominent educational and research institution located in Egypt, plays a pivotal role in advancing medical knowledge and promoting health innovations through its clinical trials. With a commitment to excellence in research, the university leverages its diverse expertise and state-of-the-art facilities to conduct rigorous clinical studies that aim to improve patient care and outcomes. By fostering collaboration among multidisciplinary teams, Zagazig University contributes significantly to the global medical community, ensuring that its clinical trials adhere to the highest ethical standards and regulatory requirements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zagazig, Sharkia, Egypt
Patients applied
Trial Officials
Ashraf A Torki, MD
Principal Investigator
Anesthesia and surgical intensive care, zagazig university, faculty of medicine
Mona A Shahin, MD
Study Director
Anesthesia and surgical intensive care, zagazig university, faculty of medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials